Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$57.77 - $65.93 $34,546 - $39,426
-598 Reduced 99.67%
2 $0
Q2 2023

Aug 14, 2023

SELL
$60.95 - $75.51 $64,180 - $79,512
-1,053 Reduced 63.7%
600 $37,000
Q2 2022

Aug 15, 2022

BUY
$66.18 - $83.18 $69,687 - $87,588
1,053 Added 175.5%
1,653 $125,000
Q2 2019

Aug 16, 2019

BUY
$73.52 - $88.7 $44,112 - $53,220
600 New
600 $50,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.5B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track First Manhattan CO Portfolio

Follow First Manhattan CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

News

Stay updated on First Manhattan CO with notifications on news.